Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | BAALC |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → BAALC |
| (<<) BCAR3 → BAALC |
| (<<) CAT → BAALC |
| (<<) CCNL1 → BAALC |
| (<<) CYB561D1 → BAALC |
| (<<) FZD4 → BAALC |
| (<<) FZD6 → BAALC |
| (<<) FZD9 → BAALC |
| (<<) GNAI1 → BAALC |
| (<<) ID1 → BAALC |
| (<<) LIF → BAALC |
| (<<) MIA3 → BAALC |
| (<<) MMP15 → BAALC |
| (<<) MOBKL2C → BAALC |
| (<<) NEDD4 → BAALC |
| (<<) PDIA3 → BAALC |
| (<<) PDK2 → BAALC |
| (<<) PRKCA → BAALC |
| (<<) PTGS2 → BAALC |
| (<<) S100P → BAALC |
| (<<) SFXN4 → BAALC |
| (<<) ST3GAL1 → BAALC |
| (<<) TCF7L1 → BAALC |
| (<<) TFF1 → BAALC |
| (<<) TSC22D1 → BAALC |
| Downstream (Children) |
|---|
| BAALC → CXCR7 (>>) |
| BAALC → EREG (>>) |
| BAALC → ETS2 (>>) |
| BAALC → FGFR3 (>>) |
| BAALC → FHIT (>>) |
| BAALC → GNG11 (>>) |
| BAALC → IER3 (>>) |
| BAALC → IL1R1 (>>) |
| BAALC → JAG1 (>>) |
| BAALC → JHDM1D (>>) |
| BAALC → KLF4 (>>) |
| BAALC → PLA2G4A (>>) |
| BAALC → PROCR (>>) |
